Amgen Loses Patent To Treat Dialysis Patients
European officials have rejected Amgen's bid to patent a treatment that helps treat overactive thyroids of dialysis patients, after ruling that chemists would have thought it was an obvious solution....To view the full article, register now.
Already a subscriber? Click here to view full article